ADVERTISEMENT

Comments?
Help us improve Portfolio Grader.


Comments?
Help us improve Portfolio Grader.


Blue Chip Growth

Stock Report: "PetMed Express, Inc." (PETS) Report Updated: Dec 15, 2014 | Print This Page

Get more stock ratings by Louis Navellier

"PetMed Express, Inc." (PETS)

Rating: Sell Volatility: Conservative
Total Grade: D Industry: Internet & Catalog Retail
Competitors: VIPS, EXPE, HSNI, MMYT

Stock Analysis

Rating: Monthly View

A
B
C
D
F
December January February March April May June July August September October November

Rating: Weekly View

This Week: D down no change
Last Week: D same no change
Two Weeks Ago: D up no change
service keys

"PetMed Express, Inc."© quotemedia

Company Profile

PetMed Express, Inc. and its subsidiaries, doing business as 1-800-PetMeds, market prescription and non-prescription pet medications, health products, and supplies for dogs and cats in the United States. The company’s non-prescription medications include flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies. Its prescription medications consist of heartworm preventatives, arthritis, thyroid, diabetes, pain medications, antibiotics, and other specialty medications, as well as generic substitutes. In addition, the company, through its Website, sells beds, crates, stairs, strollers, and other pet supplies. PetMed Express, Inc. offers its products under the Frontline Plus, K9 Advantix II, Advantage II, Heartgard Plus, Sentinel, Interceptor, Program, Revolution, Deramaxx, and Rimadyl brands. The company markets its products through national television, online, and direct mail/print advertising campaigns, as well as through telephone contact center, catalogs, brochures, and postcards. It primarily serves retail customers. PetMed Express, Inc. was founded in 1996 and is headquartered in Pompano Beach, Florida.

Recent News: "PetMed Express, Inc."